6113:TSEAMADA Co., Ltd. Analysis
Data as of 2026-06-08 - not real-time
NT$24.60
Latest Price
7/10Risk
Risk Level: Medium
Executive Summary
The stock is trading at TWD 24.6, which sits below the 20‑day SMA of 25.81 but above the 50‑day SMA of 23.57, indicating a short‑term pullback within a broader bullish framework. Technical signals are mixed: the MACD histogram is negative (-0.26) signaling bearish momentum, while the RSI at 45.7 suggests the price is not yet oversold, and volume is trending downward, raising liquidity concerns.
Fundamentally, ASEC International shows robust revenue growth of 33% year‑over‑year, yet profitability remains weak with a negative profit margin of -1.35% and a marginal operating margin of just 1.05%. The DCF fair value of roughly TWD 19.3 is well below the current price, implying the stock is overvalued. Despite a modest dividend yield of 1.9% and a low payout ratio of 10%, the company’s cash position (TWD 273M) comfortably exceeds its debt (TWD 145M), supporting dividend sustainability. However, high 30‑day volatility (≈54%) and a beta above 1 underscore elevated market risk.
Fundamentally, ASEC International shows robust revenue growth of 33% year‑over‑year, yet profitability remains weak with a negative profit margin of -1.35% and a marginal operating margin of just 1.05%. The DCF fair value of roughly TWD 19.3 is well below the current price, implying the stock is overvalued. Despite a modest dividend yield of 1.9% and a low payout ratio of 10%, the company’s cash position (TWD 273M) comfortably exceeds its debt (TWD 145M), supporting dividend sustainability. However, high 30‑day volatility (≈54%) and a beta above 1 underscore elevated market risk.
Market Outlook
Short Term
< 1 yearNeutral
Model confidence: 5/10
Key Factors
- Price below 20‑day SMA indicating near‑term weakness
- Bearish MACD histogram
- Decreasing trading volume
Medium Term
1–3 yearsNeutral
Model confidence: 6/10
Key Factors
- Strong 33% revenue growth
- Overvaluation relative to DCF fair value
- Sustainable dividend with low payout ratio
Long Term
> 3 yearsCautious
Model confidence: 7/10
Key Factors
- Negative profit margins and modest ROE
- High volatility and beta indicating market sensitivity
- Persistent overvaluation compared to intrinsic value
Key Metrics & Analysis
Financial Health
Revenue Growth33.10%
Profit Margin-1.35%
ROE-1.66%
ROA-0.59%
Debt/Equity26.64
P/B Ratio2.4
Op. Cash FlowNT$33.8M
Free Cash FlowNT$-680125
Industry P/E32.6
Technical Analysis
TrendBullish
RSI45.7
SupportNT$23.25
ResistanceNT$28.85
MA 20NT$25.81
MA 50NT$23.57
MA 200NT$21.86
MACDBearish
VolumeDecreasing
Fear & Greed Index87.88
Valuation
Fair ValueNT$19.26
GradeOvervalued
TypeGrowth
Dividend Yield1.91%
Risk Assessment
Beta1.15
Volatility53.84%
Sector RiskMedium
Reg. RiskMedium
Geo RiskMedium
Currency RiskMedium
Liquidity RiskMedium
Similar Tickers
This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.